Amphastar Pharmaceuticals (AMPH) Q2 2025 Earnings Report

436 Followers

AMPH Q2 2025 EPS Results

Actual EPS$0.85

Consensus EPS$0.74

Beat/MissBeat by +$0.11

One Year Ago EPS$0.94

Actual Revenue$174.41M

Expected Revenue$173.98M

Beat/MissBeat by +$431.00K

YoY Revenue Growth-4.38%

QuarterQ2 2025

Date08/07/2025

TimeAfter Close

Conference CallThursday, August 7, 2025

AMPH Upcoming Earnings

Amphastar Pharmaceuticals's next earnings date is estimated for November 9, 2026, based on past reporting schedules.

AMPH Q2 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 09, 2026	2026 (Q3)	0.86 / -	0.93	―
Aug 06, 2026	2026 (Q2)	0.62 / 0.91	0.85	7.06% (+0.06)
May 07, 2026	2026 (Q1)	0.70 / 0.42	0.74	-43.24% (-0.32)
Feb 26, 2026	2025 (Q4)	0.90 / 0.73	0.92	-20.65% (-0.19)
Nov 06, 2025	2025 (Q3)	0.82 / 0.93	0.96	-3.12% (-0.03)
Aug 07, 2025	2025 (Q2)	0.74 / 0.85	0.94	-9.57% (-0.09)
May 07, 2025	2025 (Q1)	0.69 / 0.74	1.04	-28.85% (-0.30)
Feb 27, 2025	2024 (Q4)	0.94 / 0.92	0.88	4.55% (+0.04)
Nov 06, 2024	2024 (Q3)	0.99 / 0.96	1.15	-16.52% (-0.19)
Aug 07, 2024	2024 (Q2)	0.77 / 0.94	0.65	44.62% (+0.29)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed